Literature DB >> 3351013

Leukoderma punctata.

R Falabella1, C E Escobar, E Carrascal, J A Arroyave.   

Abstract

Thirteen patients with vitiligo (1 segmental, 4 focal, 8 generalized) aged 7 to 38, most of them female children, developed numerous punctate hypopigmented and achromic spots. The spots measured 0.5 to 1.5 mm and were located primarily on the sun-exposed areas of the extremities; they appeared following treatment with PUVASOL. Two of these patients experienced a reduction of this leukodermic defect, whereas the remaining patients showed a stable clinical course. Dopa and Fontana stains disclosed, in most cases, decreased but not absent functional melanocytes and a marked reduction of melanin. Ultrastructural studies demonstrated slight to severe damage of keratinocytes and melanocytes similar to that previously reported in vitiligo patients. The phototoxic effect of PUVASOL therapy is suggested as a possible etiologic factor in these patients. A probable relationship among idiopathic guttate hypomelanosis, leukoderma punctata, and vitiligo is discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3351013     DOI: 10.1016/s0190-9622(88)70071-7

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  The Asian Problem of Frequent Laser Toning for Melasma.

Authors:  Brian Tian
Journal:  J Clin Aesthet Dermatol       Date:  2017-07-01

2.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

Authors:  K Ezzedine; H W Lim; T Suzuki; I Katayama; I Hamzavi; C C E Lan; B K Goh; T Anbar; C Silva de Castro; A Y Lee; D Parsad; N van Geel; I C Le Poole; N Oiso; L Benzekri; R Spritz; Y Gauthier; S K Hann; M Picardo; A Taieb
Journal:  Pigment Cell Melanoma Res       Date:  2012-05       Impact factor: 4.693

3.  Treatment of Laser Therapy-Induced Punctate Leukoderma Using a 308-nm Excimer Laser.

Authors:  Han Mi Jung; Hyub Kim; Ji Hae Lee; Gyong Moon Kim; Jung Min Bae
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.